[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
November 21, 2001

Autoimmune Disorders and Hormones

Author Affiliations
 

Not Available

Not Available

JAMA. 2001;286(19):2390. doi:10.1001/jama.286.19.2390-JHA10011-3-1

Women with autoimmune disorders often have fewer symptoms during late pregnancy. Conversely, in the year following pregnancy, symptoms often worsen and women without autoimmune disorders are at higher risk for developing them. Scientists now think that roller-coaster levels of two immune hormones, interleukin 12 (IL-12) and tumor necrosis factor ga (TNF-α), drive both phenomena.

Earlier work had suggested that the two hormones may be responsible for the tissue swelling and destruction characteristic of rheumatoid arthritis and multiple sclerosis. To follow up, George P. Chrousos, MD, and colleagues at the National Institute of Child Health and Human Development and the National Institute of Arthritis and Musculoskeletal and Skin Diseases recruited 18 women with healthy pregnancies. The researchers measured IL-12 and TNF-α levels during and after pregnancy. After birth, the women experienced threefold higher levels of IL-12 than they had during their third trimester. Similarly, TNF-α levels rose by 40% after birth.

First Page Preview View Large
First page PDF preview
First page PDF preview
×